Congenital Nephrotic Syndrome: An Atypical Presentation

Abstract We report the case of a 15-year-old boy diagnosed with congenital nephrotic syndrome (CNS) at one month of age. The genetic testing with exome sequencing identified 2 mutations in the NPHS2 gene. He started treatment with an ACE inhibitor at 9 months. Kidney biopsy conducted at the age of 5 revealed no glomerulosclerosis. He has maintained clinical stability with controlled proteinuria (significant but non-nephrotic range), and no impairment of kidney function. This case shows an atypical evolution of CNS. Considering the identified mutation it would be expected a poor prognosis with early kidney failure and need of kidney replacement therapy. However, this boy, currently 15 years old, has shown a favorable evolution under treatment with an ACE inhibitor.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-09
DOI
https://doi.org/10.21203/rs.3.rs-11454762/v1
Primary Topic
Renal Diseases and Glomerulopathies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Congenital Nephrotic Syndrome: An Atypical Presentation

Clara Gomes, Catarina de Oliveira Neves, Carolina Cordinhã, Joana Sousa et al.
Research Square
Renal Diseases and Glomerulopathies
preprint

Congenital Nephrotic Syndrome: An Atypical Presentation

Clara Gomes, Catarina de Oliveira Neves, Carolina Cordinhã, Joana Sousa, Marta Sofia da Cunha Alves Machado, Raquel Palha Martins
preprint en

Abstract

Abstract We report the case of a 15-year-old boy diagnosed with congenital nephrotic syndrome (CNS) at one month of age. The genetic testing with exome sequencing identified 2 mutations in the NPHS2 gene. He started treatment with an ACE inhibitor at 9 months. Kidney biopsy conducted at the age of 5 revealed no glomerulosclerosis. He has maintained clinical stability with controlled proteinuria (significant but non-nephrotic range), and no impairment of kidney function. This case shows an atypical evolution of CNS. Considering the identified mutation it would be expected a poor prognosis with early kidney failure and need of kidney replacement therapy. However, this boy, currently 15 years old, has shown a favorable evolution under treatment with an ACE inhibitor.

Research Square
Hospitais da Universidade de Coimbra (PT)
Good health and well-being
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon